Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIME
2012-005139-99Phase 2Active
- Sponsor
- Unicancer
- Start
- Apr 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in metastatic colorectal adenocarcinoma (mCRC), sponsored by Unicancer. Started Apr 2013; status: active.
02
Drugs
cetuximab
03
Conditions
metastatic colorectal adenocarcinoma (mCRC)
Beyond the preview
Go deeper on 2012-005139-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005139-99.